Literature DB >> 15322809

Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging.

Nike M M L Stikkelbroeck1, Ad R M M Hermus, Diana Schouten, Harold M Suliman, Gerrit J Jager, Didi D M Braat, Barto J Otten.   

Abstract

The aim of the investigation was to assess the prevalence of ovarian adrenal rest tumours and polycystic ovaries in female patients with congenital adrenal hyperplasia (CAH). Thirteen female CAH patients (median age 19.8 years, range 14.8-23.5 years) underwent transvaginal (n=6) or transabdominal (n=7) ultrasonography by a gynaecologist and MR imaging (n=13) of the ovaries (pre and post contrast-enhanced T1- and T2-weighted images). Ovarian adrenal rest tumours were defined as small hypoechoic and multifocal nodules on ultrasound and isointense lesions on T1- and hypointense on T2-weighted MR images (derived from characteristics of testicular adrenal rest tumours). Polycystic ovaries were defined as the presence of > or = 10 follicles arranged peripherally around or scattered throughout increased stroma. No ovarian adrenal rest tumours were found either on ultrasound, or by MR imaging. Polycystic ovaries were found in 2 of the 13 patients (15.4%), both with ultrasound and MR. No ovarian adrenal rest tumours were detected in these female CAH patients, which suggests that ovarian adrenal rest tumours in CAH females are rare. The prevalence of polycystic ovaries corresponded to that in the general population. From these results, we would suggest that routine ovarian imaging in CAH females is not indicated. However, when ovarian dysfunction is present, ovarian imaging is advised, first by ultrasonography, to detect ovarian adrenal rest tumours or polycystic ovaries. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322809     DOI: 10.1007/s00330-004-2329-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  20 in total

1.  Testicular adrenal rest tissue in congenital adrenal hyperplasia: comparison of MR imaging and sonographic findings.

Authors:  N A Avila; A Premkumar; D P Merke
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

2.  Accessory adrenal cortex in the broad ligament: incidence and functional significance.

Authors:  J L FALLS
Journal:  Cancer       Date:  1955 Jan-Feb       Impact factor: 6.860

3.  Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight.

Authors:  K Michelmore; K Ong; S Mason; S Bennett; L Perry; M Vessey; A Balen; D Dunger
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

4.  Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency.

Authors:  J Jääskeläinen; O Kiekara; M Hippeläinen; R Voutilainen
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

5.  Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.

Authors:  J Adams; S Franks; D W Polson; H D Mason; N Abdulwahid; M Tucker; D V Morris; J Price; H S Jacobs
Journal:  Lancet       Date:  1985 Dec 21-28       Impact factor: 79.321

6.  Gonadal and adrenal catheterization during adrenal suppression and gonadal stimulation in a patient with bilateral testicular tumors and congenital adrenal hyperplasia.

Authors:  M E Combes-Moukhovsky; M L Kottler; P Valensi; P Boudou; M Sibony; J R Attali
Journal:  J Clin Endocrinol Metab       Date:  1994-11       Impact factor: 5.958

7.  Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features.

Authors:  Nike M M L Stikkelbroeck; Harold M Suliman; Barto J Otten; Ad R M M Hermus; Johan G Blickman; Gerrit J Jager
Journal:  Eur Radiol       Date:  2003-01-18       Impact factor: 5.315

8.  Steroidogenic enzyme activities, morphology, and receptor studies of a testicular adrenal rest in a patient with congenital adrenal hyperplasia.

Authors:  R V Clark; B D Albertson; A Munabi; F Cassorla; G Aguilera; D W Warren; R J Sherins; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

9.  Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?

Authors:  J H Levin; E Carmina; R A Lobo
Journal:  Fertil Steril       Date:  1991-10       Impact factor: 7.329

10.  Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  L Ghizzoni; R Virdis; A Vottero; M Cappa; M E Street; M Zampolli; L Ibañez; S Bernasconi
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

View more
  18 in total

Review 1.  Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics.

Authors:  Agrons Michelle M; Corey T Jensen; Mouhammed Amir Habra; Christine O Menias; Akram M Shaaban; Nicolaus A Wagner-Bartak; Alicia M Roman-Colon; Khaled M Elsayes
Journal:  Br J Radiol       Date:  2017-07-14       Impact factor: 3.039

Review 2.  Imaging features of poorly controlled congenital adrenal hyperplasia in adults.

Authors:  H K Kok; M Sherlock; N A Healy; O Doody; P Govender; W C Torreggiani
Journal:  Br J Radiol       Date:  2015-07-02       Impact factor: 3.039

3.  Ovarian Adrenal Rest Tumors Undetected by Imaging Studies and Identified at Surgery in Three Females with Congenital Adrenal Hyperplasia Unresponsive to Increased Hormone Therapy Dosage.

Authors:  Hua-Dong Chen; Li-E Huang; Zhi-Hai Zhong; Zhe Su; Hong Jiang; Jing Zeng; Jun-Cheng Liu
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

Review 4.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

5.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

6.  Use of PET/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia.

Authors:  Melissa K Crocker; Stephanie Barak; Corina M Millo; Stephanie A Beall; Mahtab Niyyati; Richard Chang; Nilo A Avila; Carol Van Ryzin; James Segars; Martha Quezado; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

7.  Growth and reproductive outcomes in congenital adrenal hyperplasia.

Authors:  Todd D Nebesio; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2010-02-01

8.  Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  T H Johannsen; C P L Ripa; E Carlsen; J Starup; O H Nielsen; M Schwartz; K T Drzewiecki; E L Mortensen; K M Main
Journal:  Int J Pediatr Endocrinol       Date:  2010-10-20

Review 9.  Prostate gland development and adrenal tumor in a female with congenital adrenal hyperplasia: a case report and review from radiology perspective.

Authors:  Benjamin Fang; Francis Cho; Wendy Lam
Journal:  J Radiol Case Rep       Date:  2013-12-01

10.  Normal ovarian structure and function with normal glucose tolerance in girls with early treatment of classic congenital adrenal hyperplasia.

Authors:  Amy Fleischman; Harriet Paltiel; Jeanne Chow; Julie Ringelheim; Catherine M Gordon
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-04       Impact factor: 1.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.